SONOMA PHARMACEUTICALS, INC. Lease Obligation Incurred
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Lease Obligation Incurred of $0 for the 9-month period ending 2018-12-31, per its 10-Q filed 2019-02-14.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:CapitalLeaseObligationsIncurred · last filed 2019-02-14
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2018-12-31 was $0.00.
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2018-09-30 was $0.00.
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2018-06-30 was $0.00, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for the quarter ending 2018-03-31 was $0.00, a 100.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for fiscal 2018 was $180.00K, a 25.62% decline from fiscal 2017.
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for fiscal 2017 was $242.00K.
- SONOMA PHARMACEUTICALS, INC. lease obligation incurred for fiscal 2016 was $0.00.
| Period end | Lease Obligation Incurred 3 month | Lease Obligation Incurred 6 month | Lease Obligation Incurred 9 month | Lease Obligation Incurred 12 month |
|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 10-Q · filed 2019-02-14 | $0.00 derived: sum of 4 quarters · filed 2019-02-14 |
| 2018-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $0.00 derived: sum of 3 quarters · filed 2018-11-08 | $0.00 derived: sum of 4 quarters · filed 2019-02-14 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-08 | $0.00 derived: sum of 2 quarters · filed 2018-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $0.00 derived: sum of 4 quarters · filed 2019-02-14 |
| 2018-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $0.00 derived: sum of 3 quarters · filed 2019-02-14 | $180.00K 10-K · filed 2018-06-26 |
| 2017-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-02-14 | $0.00 derived: sum of 2 quarters · filed 2019-02-14 | $180.00K 10-Q · filed 2019-02-14 | $422.00K derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $180.00K 10-Q · filed 2018-11-08 | $422.00K derived: sum of 3 quarters · filed 2018-11-08 | $422.00K derived: sum of 4 quarters · filed 2018-11-08 |
| 2017-06-30 | $180.00K 10-Q · filed 2018-08-08 | $422.00K derived: sum of 2 quarters · filed 2018-08-08 | $422.00K derived: sum of 3 quarters · filed 2018-08-08 | $422.00K derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-06-26 | $242.00K derived: sum of 2 quarters · filed 2018-06-26 | $242.00K derived: sum of 3 quarters · filed 2018-06-26 | $242.00K 10-K · filed 2018-06-26 |
| 2016-12-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-14 | $0.00 derived: sum of 2 quarters · filed 2018-02-14 | $0.00 10-Q · filed 2018-02-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-14 | $0.00 10-Q · filed 2017-11-14 | ||
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | |||
| 2016-03-31 | $0.00 10-K · filed 2017-06-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |